Health Care & Life Sciences » Pharmaceuticals | Humanwell Healthcare

Humanwell Healthcare | Cash Flow

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
601
636
853
1,080
2,318
1,961
Depreciation, Depletion & Amortization
131
171
262
433
533
574
Other Funds
761
24
1,461
559
587
3,508
Funds from Operations
918
991
1,294
1,686
1,525
2,150
Changes in Working Capital
393
481
914
1,129
1,465
1,536
Net Operating Cash Flow
524
510
379
556
60
614
Capital Expenditures
911
897
829
1,244
1,683
Sale of Fixed Assets & Businesses
4
2
1
491
3,256
Purchase/Sale of Investments
528
233
626
751
1,371
Net Investing Cash Flow
1,395
1,063
2,261
5,440
3,490
Cash Dividends Paid - Total
49
63
96
129
141
Issuance/Reduction of Debt, Net
411
762
1,278
6,271
3,952
Net Financing Cash Flow
1,123
723
2,642
5,583
4,397
Net Change in Cash
249
169
764
662
892
Free Cash Flow
386
387
449
688
1,619
Deferred Taxes & Investment Tax Credit
5
2
6
4
17
29
Net Assets from Acquisitions
46
42
781
4,002
3,692
Other Sources
85
107
30
113
-
Exchange Rate Effect
-
3
3
37
75
Other Uses
-
-
56
46
-

About Humanwell Healthcare

View Profile
Address
No. 666 Gaoxin Avenue
Wuhan Hubei 430075
China
Employees -
Website http://www.humanwell.com.cn
Updated 07/08/2019
Humanwell Healthcare (Group) Co., Ltd. engages in the research and development, production, and sale of medical products. It focuses on chemical preparations, chemical raw materials, Chinese medicine, and biological agents. Its business segment covers pharmaceutical manufacturing, medical service, distribution, and global presence or international market.